| __timestamp | TG Therapeutics, Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 24518692 | 5078000000 |
| Thursday, January 1, 2015 | 19886580 | 4717000000 |
| Friday, January 1, 2016 | 12631689 | 5096000000 |
| Sunday, January 1, 2017 | 21977998 | 4986000000 |
| Monday, January 1, 2018 | 20759000 | 4214000000 |
| Tuesday, January 1, 2019 | 20838000 | 3806000000 |
| Wednesday, January 1, 2020 | 121812000 | 3671000000 |
| Friday, January 1, 2021 | 152137000 | 3528000000 |
| Saturday, January 1, 2022 | 83231000 | 3445000000 |
| Sunday, January 1, 2023 | 122706000 | 3498000000 |
| Monday, January 1, 2024 | 3702000000 |
Unleashing insights
In the ever-evolving pharmaceutical industry, understanding the financial dynamics of key players is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Teva Pharmaceutical Industries Limited and TG Therapeutics, Inc. from 2014 to 2023. Over this period, Teva's SG&A expenses have shown a downward trend, decreasing by approximately 31% from 2014 to 2023. In contrast, TG Therapeutics experienced a significant rise, with expenses increasing nearly fivefold, peaking in 2021. This divergence highlights the contrasting strategies of these companies: Teva's focus on cost optimization versus TG Therapeutics' aggressive investment in growth. As the pharmaceutical landscape continues to shift, these financial insights provide a window into the strategic priorities of these industry leaders.
Breaking Down SG&A Expenses: Johnson & Johnson vs TG Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Amgen Inc. and Teva Pharmaceutical Industries Limited
Breaking Down SG&A Expenses: argenx SE vs Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Limited and United Therapeutics Corporation: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Teva Pharmaceutical Industries Limited vs Ultragenyx Pharmaceutical Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Teva Pharmaceutical Industries Limited and CRISPR Therapeutics AG
Teva Pharmaceutical Industries Limited vs Arrowhead Pharmaceuticals, Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Teva Pharmaceutical Industries Limited or Supernus Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Sarepta Therapeutics, Inc. vs TG Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of TG Therapeutics, Inc. and MorphoSys AG
Who Optimizes SG&A Costs Better? TG Therapeutics, Inc. or Agios Pharmaceuticals, Inc.
Comparing SG&A Expenses: TG Therapeutics, Inc. vs Celldex Therapeutics, Inc. Trends and Insights